Skip to main content

Table 1 Checklist items for reporting modelling studies

From: Reporting guidelines for modelling studies

Dimension of Quality

Reporting item

Philips

Unal

ISPOR

Nuijten

Stout

Drummond

Kopec

STRUCTURE

        

Decision problem/objective

Is there a clear statement of the decision problem?

x

  

x

 

x

 
 

Is the objective of the evaluation specified and consistent with the stated decision problem?

x

  

x

   
 

Is the primary decision-maker specified?

x

    

x

 

Scope/perspective

Is the perspective of the model clearly stated?

x

 

x

x

   
 

Are the model inputs consistent with the stated perspective?

x

    

x

 
 

Are definitions of the variables in the model justified?

      

x

 

Has the scope of the model been stated and justified?

x

     

x

 

Are the outcomes of the model consistent with the perspective, scope and overall objective of the model?

x

      

Rationale for structure

Is the structure of the model consistent with a coherent theory of the health condition under evaluation?

x

 

x

   

x

 

Are the sources of data used to develop the structure of the model specified?

x

      
 

Are the causal relationships described by the model structure justified appropriately?

x

      

Structural assumptions

Are the structural assumptions clearly stated and justified?

x

x

x

x

   
 

Are the structural assumptions reasonable given the overall objective, perspective and scope of the model?

x

      

Strategies/comparators

Is there a clear definition of the options under evaluation?

x

 

x

x

   
 

Have all feasible and practical options been evaluated?

x

      
 

Is there justification for the exclusion of feasible options?

x

      

Model type

Is the chosen model type appropriate given the decision problem and specified causal relationships within the model?

x

  

x

  

x

Time horizon

Is the time horizon of the model sufficient to reflect all important differences between options?

x

 

x

x

   
 

Are the time horizon of the model, the duration of treatment and the duration of treatment effect described and justified?

x

      

Disease states/pathways

Do the disease states (state transition model) or the pathways (decision tree model) reflect the underlying biological process of the disease in question and the impact of the interventions?

x

 

x

x

   

Cycle length

Is the cycle length justified?

x

 

x

x

   

Parsimony

Is there indication that the structure of the model is as simple as possible and that any simplifications are justified?

  

x

    

DATA

        

Data identification

Are the data identification methods transparent and appropriate given the objectives of the model?

x

 

x

x

   
 

Are results reported in a way that allows the assessment of the appropriateness of each parameter input and each assumption in the target settings?

     

x

 
 

Where choices have been made between data sources, are these justified appropriately?

x

    

x

x

 

Where data from different sources are pooled, is this done in a way that the uncertainty relating to their precision and possible heterogeneity is adequately reflected?

     

x

 
 

Are the data used to populate the model relevant to the target audiences (i.e., decision-makers) and settings?

     

x

 
 

Has particular attention been paid to identifying data for the important parameters in the model?

x

      
 

Has the quality of the data been assessed appropriately?

x

x

    

x

 

Where expert opinion has been used, are the methods described and justified?

x

 

x

x

  

x

Data modelling

Is the data modelling methodology based on justifiable statistical and epidemiological techniques?

x

 

x

    

Baseline data

Is the choice of baseline data described and justified?

x

      
 

Are transition probabilities calculated appropriately?

x

 

x

x

   

Treatment effects

If relative treatment effects have been derived from trial data, have they been synthesized using appropriate techniques?

x

 

x

    
 

Have the methods and assumptions used to extrapolate short-term results to final outcomes been documented and justified? Have alternative assumptions been explored through sensitivity analysis?

x

 

x

x

   
 

Have assumptions regarding the continuing effect of treatment once treatment is complete been documented and justified? Have alternative assumptions been explored through sensitivity analysis?

x

      

Risk factors

Has evidence supporting the modeling of risk factors as having an additive or multiplicative effect on baseline probabilities or rates of disease incidence or mortality been presented?

  

x

    

Data incorporation

Have all data incorporated into the model been described and referenced in sufficient detail?

x

 

x

x

   
 

Has the use of mutually inconsistent data been justified (i.e., are assumptions and choices appropriate)?

x

      
 

Is the process of data incorporation transparent?

x

 

x

    
 

If data have been incorporated as distributions, has the choice of distribution for each parameter been described and justified?

x

 

x

    
 

If data have been incorporated as distributions, is it clear that second order uncertainty is reflected?

x

 

x

    

Assessment of uncertainty

Have the four principal types of uncertainty been addressed?

x

      
 

If not, has the omission of particular forms of uncertainty been justified?

x

      

Methodological

Have methodological uncertainties been addressed by running alternative versions of the model with different methodological assumptions?

x

      

Structural

Is there evidence that structural uncertainties have been addressed via sensitivity analysis?

x

 

x

    

Heterogeneity

Has heterogeneity been dealt with by running the model separately for different subgroups?

x

 

x

    

Parameter

Are the methods of assessment of parameter uncertainty appropriate?

x

 

x

x

 

x

x

 

If data are incorporated as point estimates, are the ranges used for sensitivity analysis stated clearly and justified?

x

x

     
 

Which sensitivity analyses were carried out?

 

x

     

CONSISTENCY

        

Internal consistency

Is there evidence that the mathematical logic of the model has been tested thoroughly before use?

x

 

x

   

x

External consistency

Are any counterintuitive results from the model explained and justified?

x

 

x

x

   
 

If the model has been calibrated against independent data, have any differences been explained and justified?

x

x

     
 

How was the model calibrated?

 

x

     
 

Calibration - description of source data

    

x

 

x

 

Calibration - description of search algorithm

    

x

 

x

 

Calibration - description of goodness-of-fit metric

    

x

 

x

 

Calibration - description of acceptance criteria

    

x

 

x

 

Calibration - description of stopping rule

    

x

 

x

 

Have the results of the model been compared with those of previous models and any differences in results explained?

x

 

x

x

  

x

VALIDITY

        

Output plausibility

Has evidence of face validity - evaluation by experts in the subject matter area for a wide range of input conditions and output variables, over varying time horizons – been presented?

      

x

Predictive validity

Was the validity of the model tested?

 

x

 

x

x

 

x

 

Is there a description of how the validity of the model was checked?

 

x

  

x

  
 

How was the validity quantified? (e.g., % explained)

 

x

     

COMPUTER IMPLEMENTATION

Is the software used in the study listed and its choice justified?

 

x

 

x

  

x

TRANSPARENCY

Is the model available to the reader?

 

x

     
 

Is a detailed document describing the calibration methods available?

    

x

  
 

Do the authors provide relevant appendices?

   

x

   

SPONSORSHIP

Is disclosure of relationship between study sponsor and performer of the study provided?

   

x

  Â